Anvillea garcinii subsp. radiata
Anvillea garcinii subsp. radiata · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Anvillea garcinii subsp. radiata is a botanical species of significant medicinal interest due to its diverse pharmacological activities, including antidiabetic, antihyperglycemic, antihyperlipidemic, and antioxidant properties. The plant's therapeutic potential is driven by key chemical constituents such as 3,5-Dicaffeoylquinic acid, Hispidulin, Isorhamnetin, and Jaceosidin. Recent research has explored its efficacy in addressing complex health conditions, ranging from Alzheimer's Disease to the challenges posed by COVID-19 and SARS-CoV-2. To study these effects, various preparations are utilized, including aqueous extracts, butanol extracts, and chloroform extracts. Furthermore, scientific investigations often employ six different types of extracts, spanning both water-soluble and organic solvents, to isolate its bioactive compounds.
- Synonyms
- Anvillea Australis · Anvillea Faurei · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Anvillea garcinii subsp. radiata is a botanical taxon that is recognized by several distinct scientific names within taxonomic literature. This specific subspecies is formally associated with the synonym Anvillea australis. Furthermore, researchers often refer to this plant using the alternative designation Anvillea faurei. The nomenclature also encompasses the name Sycodium radiatum, reflecting its complex classification history. Understanding these various synonyms is essential for ensuring accuracy in botanical identification and academic study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Anvillea garcinii subsp. radiata is a distinct biological entity that belongs to the kingdom Plantae. Within this vast realm, it is classified under the class Equisetopsida. Its taxonomic lineage continues through the order Asterales, placing it in a specific evolutionary group. Furthermore, this subspecies is a member of the Asteraceae family, a group known for its diverse floral structures. Ultimately, it is defined by its membership in the genus Anvillea, marking its unique place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Anvillea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Anvillea garcinii subsp. radiata is a distinct botanical subspecies primarily found across the diverse landscapes of the African continent. Its geographic reach spans the northern regions, where it is established within the territories of Algeria, Libya, Tunisia, and Morocco. In addition to these North African habitats, the plant extends its presence into West Tropical Africa. Specifically, it can be located within the borders of Mauritania, showcasing a broad environmental adaptability. This distribution highlights the important ecological role the subspecies plays throughout these varying African climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Anvillea garcinii subsp. radiata has demonstrated significant therapeutic potential through its various biological activities. Research indicates that the plant possesses potent antidiabetic and hypoglycemic properties, which assist in the management of blood glucose levels. Furthermore, its antihyperglycemic effects contribute to the stabilization of postprandial hyperglycemia in metabolic models. The plant also exhibits important antihyperlipidemic activity, aiding in the improvement of lipid profiles. Finally, its strong antioxidant capabilities provide essential protection against oxidative stress in various tissues.
Compounds
Anvillea garcinii subsp. radiata serves as a rich source of various bioactive phytocompounds that show significant therapeutic potential. Research has identified that this plant contains several key constituents, including hispidulin and isorhamnetin. Additionally, the presence of jaceosidin and nepetin within its profile contributes to its complex chemical makeup. The plant also contains spinacetin, which has been highlighted for its potential efficacy in targeting specific viral proteins. Together, these identified compounds underscore the medicinal importance of the species in modern pharmacological studies.
Conditions
Anvillea garcinii subsp. radiata demonstrates significant therapeutic potential by acting as an inhibitor of acetylcholinesterase to treat Alzheimer's disease. Research indicates that its phytocompounds can target the main protease of SARS-CoV-2, offering a promising strategy to treat COVID-19. In studies involving L-NAME induced hypertensive rats, the plant's aqueous extract has been shown to effectively treat hypertension. Specifically, the administration of the extract leads to a significant reduction in diastolic blood pressure (DBP). Furthermore, the plant successfully treats elevated mean blood pressure (MBP) through its potent antihypertensive and vasorelaxant activities.
Preparations
Anvillea garcinii subsp. radiata is prepared as an aqueous extract to evaluate its antihypertensive and non-toxic properties in various studies. Researchers have also utilized six extracts, consisting of both water-soluble and organic varieties, to analyze the plant's phytochemical content and antioxidant abilities. Additionally, the plant is prepared as butanol extracts, which have demonstrated dose-dependent hypoglycemic actions in diabetic models. The species is also processed as a chloroform extract to isolate specific compounds like 9α-hydroxy-parthenolide. Furthermore, the chloroformic extract of the plant has shown significant anti-fungal activity against Penicillium italicum.